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Background: In head and neck squamous cell carcinoma (HNSCC), invasiveness and metastasis of cancer
cells contribute to make this insidious disease a major cause of mortality. Epithelial-mesenchymal
transition (EMT) is generally considered to be the major mechanism of cancer metastasis. We previ-
ously demonstrated the crucial role of the EMT regulator Twist1 in HNSCC. A growing body of evidence
suggests that microRNAs play essential roles in cancer progression and metastasis. The aim of this study
was to investigate the role of microRNA in Twist1-mediated cancer metastasis.
Materials and methods: The HNSCC cell lines FaDu, SAS, OECM1 and CAL-27, were used in this study.
Quantitative RT-PCR for microRNAs and Western blot were performed on four HNSCC cell lines to study
the molecular mechanisms involved.
Results: Expression of the miR-29 family, including miR-29a, b, and c were increased in Twist1-
overexpressing HNSCC cells. Furthermore, we discovered that SIN3A, a co-repressor of another EMT
regulator Snail, is a target of miR-29s. With our results, we demonstrated that Twist1 modiﬁes the
function of gene expression through microRNA machinery.
Conclusion: We herein have delineated the regulatory mechanism of the Twist1-miR29-SIN3A axis in
HNSCC.
Copyright © 2016, The Chinese Oncology Society. Production and hosting by Elsevier B.V. This is an open
access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).1. Introduction
Epithelial-mesenchymal transition (EMT) is a process by which
epithelial cells lose their polarity and are converted to a mesen-
chymal phenotype; recently, this has been regarded as the critical
event that can induce morphogenetic changes during embryonic
development, organ ﬁbrosis and tumor metastasis.1e4 Phenotypic
changes of EMT include the downregulation of epithelial markers
(e.g., E-cadherin, desmoplakin and plakoglobin) and upregulation
of mesenchymal markers (e.g., vimentin, ﬁbronectin and a-smooth
muscle actin).1e4 The initiation of EMT is hallmarked by the
repression of E-cadherin. Several mechanisms including tran-
scriptional repression4 and promoter hypermethylation5 are shown
to repress the expression of CDH, the gene encoding E-cadherin,ne, National Yang-Ming Uni-
aiwan.
ang).
ncology Society.
Society. Production and hosting byand induce EMT. A number of transcription factors, including Snail
(also known as Snail1), Slug (also known as Snail2), Twist1 (also
known as Twist), Zeb1, SIP1 and E47, participate in the transcrip-
tional repression of CDH1 during EMT.1e4 In addition, emerging
evidence highlights the role of chromatin modiﬁcation in CDH1
repression: Snail interacts with HDAC1-HDAC2-SIN3A complex to
facilitate the CDH1 repression through chromatin modiﬁcation.6
We previously also demonstrated that regulation of the chro-
matin modiﬁer Bmi1 by Twist1 contributes to the suppression of
CDH1 by Twist1.7 In human cancers, accumulated evidence sug-
gests the critical role of EMT in the progression and dissemination
of different types of cancers. Notably, the increased expression
levels of EMT regulators (e.g., Twist1, Snail, Slug, SIP1, E47, Zeb1)
have been reported to be associated with an aggressive phenotype
and worse prognosis in different cancers, including HNSCC.8e13
Recent studies indicate that hypoxia is one of the major causes
contributing to the progression, metastasis and treatment resis-
tance of HNSCC.8 The linkage between EMT and hypoxia for pro-
moting invasive phenotype of cancers has become clear in recent
years. We recently demonstrated that direct regulation of TWIST1Elsevier B.V. This is an open access article under the CC BY-NC-ND license (http://
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Furthermore, activation of other EMT regulators, including Snail,
SIP1, Zeb1 and E47 has also been shown under hypoxic con-
ditions.8,15e18 Although the importance of hypoxia-induced EMT
has been highlighted, the interplay between different EMT regu-
lators and their unique roles in hypoxia-mediated EMT has never
been previously addressed.
MicroRNAs are small non-coding RNA molecules that suppress
gene expression by interactingwith the 30-untranslated regions (30-
UTRs) of target mRNAs.19 MicroRNAs have been shown to be
involved in a wide range of pivotal biological processes in
mammalian cells, including cell growth, development, prolifera-
tion, differentiation and death. Regarding the role of microRNA in
cancer, more than 50% of annotated human microRNA genes are
located in fragile chromosomal regions that are susceptible to
ampliﬁcation, deletion or translocation in the tumor development
process.20 Recent evidence has indicated that some microRNAs
function either as oncogenes or as tumor suppressors, and
expression proﬁling has revealed characteristic microRNA signa-
tures in certain human cancers.21
The microRNA-29 family members, including miR-29a, miR-
29b, and miR-29c, have been shown to play the critical role of
tumorigenesis and metastasis in different kinds of human cancer.
Some reports suggest the oncogenic role of miR-29 in cancer cells,
in that miR-29a induces self-renewal capacity in hematopoiesis and
initiates acute myeloid leukemia (AML).22 Also, miR-29a suppresses
the epithelial polarity and promotes metastasis of breast cancer
cells.23 In contrast, the tumor suppressive effect of miR-29 has also
been reported. It is well-established that miR-29s enhances
apoptosis of hepatocellular carcinoma (HCC) cells, and down-
regulation of miR-29s is associated with a worse survival of HCC
patients.24 Furthermore, miR-29b induces global methylation
through directly targeting DNMT3A, 3B, and indirectly targeting
DNMT1 in AML25; miR-29b modulates KIT expression by targeting
SP1 and is also down-regulated by aberrant expression of KIT.26
Therefore, the deﬁnitive effect of the miR-29 family on different
types of human cancers remains inconclusive.
In this study, our results showed that Twist1 upregulates miR-
29s expression in HNSCC, and SIN3A is a potential target of miR-
29. We aimed to investigate the role of regulation of microRNA
machinery in Twist1-induced metastatic phenotype, and the
mechanism of Twist1-mediated target gene regulation through
microRNAs in HNSCC.
2. Materials and methods
2.1. Cell line, plasmids
Human embryonic kidney 293T cells and different human
HNSCC cell lines (e.g., FADU, OECM-1, SAS, CAL-27) were used in
this study. Construction of expression vectors and short hairpin
RNAvector were followed pursuant to protocol.
2.2. MicroRNA microarray analyses
An Agilent human miRNA Microarray R14 V2 was used for
microRNA microarray analysis.
2.3. Reverse transcription and real-time quantitative PCR analysis
Reverse transcription was performed using random primers
(Invitrogen Corporation, Carlsbad, CA, USA) for mRNAs, or by using
speciﬁc stem-loop oligonucleotides for miRNAs.10 Real-time quan-
titative PCR was performed using the StepOnePlus real-time PCR
system (Applied Biosystems Inc., Foster City, CA, USA). GAPDH wasselected as an internal control for mRNA, and U6 non-coding small
nuclear RNA was used as a control for miRNA expression. The re-
sults were calculated by use of the 2-△△CT method.
2.4. Western blot analysis
Cells were harvested and lysed, and protein content was
determined by the Bradford method. Protein extracts were loaded
onto SDS-PAGE and transferred to nitrocellulose ﬁlters. The ﬁlters
were probed with a primary antibody and then a secondary anti-
body. Signals were thereafter developed using an ECL chem-
iluminescence kit.
3. Results
3.1. Twist1 upregulates the expression of miR-29 a/b/c in HNSCC
cells
To investigate the potential downstream microRNAs in the
Twist1-regulated metastatic process of HNSCC cells, we performed
miRNA microarray in the HNSCC cell line FaDu overexpressing
Twist1 (FaDu-Twist1) versus control clone. The result showed
several candidate microRNAs, including miR-29s, miR-125, miR-
222 and let-7i, were positively or negatively correlated with the
expression level of Twist1. Interestingly, the members of miR-29
family including miR-29a, b and c were all upregulated in FaDu-
Twist1 clone (Fig 1A). Quantitative RT-PCR was performed to vali-
date the result from microarray, and increased expression of miR-
29 family members was shown in FaDu-Twist1 clone (Fig 1B). To
further conﬁrm the association between the expression levels of
Twist1 and miR-29 family members in different HNSCC cell lines,
quantitative RT-PCR for microRNAs and Western Blot analysis for
Twist1 were performed in four HNSCC cell lines FaDu, SAS, OECM1
and CAL-27. The result conﬁrmed the correlation between the
expression of Twist1 and miR-29s: in the low-invasive FaDu and
CAL-27 cells, the expressions of Twist1 and miR-29s were both low.
In contrast, the highly invasive SAS and OECM-1 cells showed an
elevated Twist1 andmiR-29 levels (Fig.1C). All these results suggest
the positive correlation between miR-29s and Twist1.
Next, we delineated the mechanism of transcriptional regula-
tion of miR-29 family members by Twist1, and we analyzed the
promoter sequence of miR-29s. It shows that miR-29a and miR-
29b1 are located in the same pseudogene and share the same
promoter, and miR-29b2 and miR-29c are in the same psudogene.
Meanwhile, several putative Twist1-binding sites, i.e., the “E-
boxes”, are found in both promoters (Fig. 2).
3.2. MiR-29 downregulates the expression of SIN3A
We continue to work on ﬁnding the putative targets of miR-29
family members. Because the seed region in all miR-29 family
members is identical (Fig 3A), we tried to ﬁnd the common target in
miR-29s through bioinformatic prediction and validation. Tar-
getScan and PicTar were applied to analyze the putative miR-29s
targeting genes, and real-time PCR was used to validate the
expression of the target. SIN3A, Dicer, HDAC4, and Sp1 were found
to be potential targets of miR-29s through bioinformatic prediction
and PCR validation (Fig. 3A, B). Among them, we focused on SIN3A,
which is a member of the Snail corepressor complex and interacts
with HDAC1/HDAC2, leading to chromatin modiﬁcation and
silencing of CDH1 by promoter methylation.6 To conﬁrm the
regulation of SIN3A by miR-29s, transient expression of miR-29
family member microRNAs into HEK-293T cells was performed
and the result showed a decreased SIN3A protein expression after
expression of miR-29s (Fig. 3C).
Fig. 1. The positive correlation between the expression level of miR-29 a/b/c and Twist1 in HNSCC cells. (A) Heat map presentation of the microRNA microarray analysis in FaDu-
control vs. FaDu-Twist1. It shows that miR-29a/b/c, miR-125B, miR-222 are upregulated in FaDu-Twist1, and Let-7i is downregulated in FaDu-Twist1. (B) Real-time PCR of miR-29a/b/
c (upper) andWestern blot analysis of Twist1 (lower) in FaDu-Twist1 vs. FaDu-control. (C) Real-time PCR of miR-29a/b/c (upper) andWestern blot analysis of Twist1 (lower) in FaDu,
CAL27, SAS and OECM1 cells.
Fig. 2. Analysis of miR-29a/b1 and miR-29b2/c promoter. Upper panel: miR-29a/b1 promoter is located at chromosome 7 and contains seven E-boxes. Lower panel: miR-29b2/c is
located at chromosome 1 and contains nine E-boxes.
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miR-29 in HNSCC cells
We further conﬁrmed the Twist1-miR-29-SIN3A signal axis in
HNSCC cells: in low-endogenous Twist1 FaDu cells, Twist1-
overexpressing clones were associated with a decreased HDAC4,
Sp1, and SIN3A level (Fig. 4). These data indicate that the Twist1-miR-29s-SIN3A axis indeed existed in HNSCC cells. Twist1 regu-
lates target genes expression through miR-29 family miRNAs.
4. Discussion
The signiﬁcance and rationale of the project is that we investi-
gated the involvement of microRNA machinery in Twist1-induced
Fig. 3. Mining of putative miR-29a/b/c targets. (A) Upper panel: miR-29a, b, and c have the same seed region (red color). Lower panel: Using Pictar and TargetScan as the tools for
analyzing the targets of miR-29s, SIN3A, Sp1, HDAC4, and Dicer were found to be the putative targets of miR-29s. (B) Quantitative RT-PCR analysis of Twist1, SIN3A, Sp1, HDAC4 and
Dicer in four HNSCC cell lines FaDu, CAL-27, SAS and OECM1. A negative correlation between Twist1 and the putative miR-29 targets were shown. (C) Left panel: miR-29s were
transfected in HEK-293T and the expression of microRNAs were conﬁrmed by quantitative RT-PCR. Right panel: Western blot analysis of SIN3A in HEK-293T cells transfected with
miR-29a/b/c vs. control.
Fig. 4. Expression of Twist1 inFaDu cells was associated with the suppression of SIN3A and other putative targets. (A) Quantitative RT-PCR analysis of SIN3A, Sp1, and HDAC4 in
FaDu-Twist1 vs. FaDu-control. (B) Western blot analysis of SIN3A in FaDu-control vs. FaDu-Twist1.
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metastasis has been extensively investigated. Meanwhile,
emerging evidence supports the role of microRNAs in cancer
metastasis. However, the mechanistic linkage between EMT regu-
lators and microRNAs is relatively limited. Our study aimed to
investigate the regulation of a less-investigated microRNA, miR-29,
by Twist1 through the logical approach. Such research could sub-
stantially contribute to the elucidation of the role of microRNA
machinery in EMT and metastasis.
Although EMT can be induced by different factors under exog-
enous stimuli,1,2 it is intriguing to consider whether these EMT
inducers are redundant because of their mechanistic similarity in
EMT induction. The interplay and underlying mechanism between
EMT regulators during metastatic evolution remain elusive. Our
results show that SIN3A is regulated by Twist1 through miR-29.
Since SIN3A is a critical co-repressor in Snail-suppressed target
genes, our ﬁnding suggests that miR-29-regulated SIN3A may play
a critical role in the interplay between Snail and Twist1.
In summary, our ﬁnding indicates that in HNSCC, Twist1 regu-
lates the expression of SIN3A through miR-29 family miRNAs,
suggesting an alternative mechanism for Twist1 to regulate target
genes through miRNAs. The potential role of miR-29 in the inter-
play between Snail and Twist1, and the importance in HNSCC
metastasis require further studies to conﬁrm.Conﬂict of interest
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